Gevo insider plans sale of 39,957 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gevo, Inc. insider Christopher Ryan has filed to sell up to 39,957 shares of common stock through Stifel Nicolaus & Company on the Nasdaq on or after August 6, 2026, with an indicated aggregate market value of $61,765.53 for the planned sale.
The filing references 88,740 shares of common stock acquired as Restricted Stock Awards on August 3, 2023 as equity compensation. It also lists recent sales by Ryan of 87,700 shares for $154,334.00 on May 27, 2026 and 35,196 shares for $50,161.00 on June 12, 2026, and notes 243,411,329 shares of Gevo common stock outstanding.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Awards financial
Equity Compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the GEVO Form 144 filing by Christopher Ryan disclose?
What equity compensation information for GEVO is included in Christopher Ryan’s filing?
Which broker and market are involved in the planned GEVO stock sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.